Literature DB >> 15322089

MeCP2 behaves as an elongated monomer that does not stably associate with the Sin3a chromatin remodeling complex.

Robert J Klose1, Adrian P Bird.   

Abstract

MeCP2 is a transcription factor that recognizes and binds symmetrically methylated CpG dinucleotides to repress transcription. MeCP2 can associate with the Sin3a/histone deacetylase corepressor complex and mediate repression in a histone deacetylase-dependent manner. In extracts from rodent tissues, cultured cells, and Xenopus laevis oocytes, we find that only a small amount of mammalian MeCP2 interacts with Sin3a and that this interaction is not stable. Purification of rat brain MeCP2 (53 kDa) indicates no associated proteins despite an apparent molecular mass by size exclusion chromatography of 400-500 kDa. Biophysical analysis demonstrated that the large apparent size was not because of homo-multimerization, as MeCP2 consistently behaves as a monomeric protein that has an elongated shape. Our findings indicate the MeCP2 is not an obligate component of the Sin3a corepressor complex and may therefore engage a more diverse range of cofactors for repressive function.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15322089     DOI: 10.1074/jbc.M408284200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

1.  A brain-derived MeCP2 complex supports a role for MeCP2 in RNA processing.

Authors:  Steven W Long; Jenny Y Y Ooi; Peter M Yau; Peter L Jones
Journal:  Biosci Rep       Date:  2011-10       Impact factor: 3.840

Review 2.  Binding of the Rett syndrome protein, MeCP2, to methylated and unmethylated DNA and chromatin.

Authors:  Jeffrey C Hansen; Rajarshi P Ghosh; Christopher L Woodcock
Journal:  IUBMB Life       Date:  2010-10       Impact factor: 3.885

Review 3.  Chromatin architectural proteins.

Authors:  Steven J McBryant; Valerie H Adams; Jeffrey C Hansen
Journal:  Chromosome Res       Date:  2006       Impact factor: 5.239

4.  MBD2/NuRD and MBD3/NuRD, two distinct complexes with different biochemical and functional properties.

Authors:  Xavier Le Guezennec; Michiel Vermeulen; Arie B Brinkman; Wieteke A M Hoeijmakers; Adrian Cohen; Edwin Lasonder; Hendrik G Stunnenberg
Journal:  Mol Cell Biol       Date:  2006-02       Impact factor: 4.272

5.  Multiple modes of interaction between the methylated DNA binding protein MeCP2 and chromatin.

Authors:  Tatiana Nikitina; Xi Shi; Rajarshi P Ghosh; Rachel A Horowitz-Scherer; Jeffrey C Hansen; Christopher L Woodcock
Journal:  Mol Cell Biol       Date:  2006-11-13       Impact factor: 4.272

Review 6.  Evolving role of MeCP2 in Rett syndrome and autism.

Authors:  Janine M LaSalle; Dag H Yasui
Journal:  Epigenomics       Date:  2009-10       Impact factor: 4.778

Review 7.  Recent advances in MeCP2 structure and function.

Authors:  Kristopher C Hite; Valerie H Adams; Jeffrey C Hansen
Journal:  Biochem Cell Biol       Date:  2009-02       Impact factor: 3.626

8.  Rett syndrome mutations abolish the interaction of MeCP2 with the NCoR/SMRT co-repressor.

Authors:  Matthew J Lyst; Robert Ekiert; Daniel H Ebert; Cara Merusi; Jakub Nowak; Jim Selfridge; Jacky Guy; Nathaniel R Kastan; Nathaniel D Robinson; Flavia de Lima Alves; Juri Rappsilber; Michael E Greenberg; Adrian Bird
Journal:  Nat Neurosci       Date:  2013-06-16       Impact factor: 24.884

Review 9.  DNA methylation and methyl-CpG binding proteins: developmental requirements and function.

Authors:  Ozren Bogdanović; Gert Jan C Veenstra
Journal:  Chromosoma       Date:  2009-06-09       Impact factor: 4.316

10.  A temporal threshold for formaldehyde crosslinking and fixation.

Authors:  Lars Schmiedeberg; Pete Skene; Aimée Deaton; Adrian Bird
Journal:  PLoS One       Date:  2009-02-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.